M&A Deal Summary |
|
|---|---|
| Date | 2017-02-06 |
| Target | SeaView Research |
| Sector | Life Science |
| Buyer(s) | Quotient Sciences |
| Deal Type | Add-on Acquisition |
SEARCH BY
Quotient Sciences is a provider of outsourced, early-stage drug development services to the pharmaceutical industry. Quotient Sciences has brought innovation to the pharmaceutical services sector through its unique Translational Pharmaceutics® platform, which is proven to accelerate development timelines, reduce development costs, and drive improvement in R&D productivity. Quotient Sciences was founded in 1990 and is based in Nottingham, England.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 5 |
| Sector: Life Science M&A | 2 of 5 |
| Type: Add-on Acquisition M&A Deals | 2 of 4 |
| State: Florida M&A | 1 of 1 |
| Country: United States M&A | 1 of 2 |
| Year: 2017 M&A | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-12-16 |
Co-Formulate
Nottingham, United Kingdom Co-Formulate Ltd. is a contract product development company that provides a comprehensive range of formulation development, analytical and regulatory services to clients in the pharmaceutical, OTC consumer healthcare, personal care, nutritional supplements and veterinary industries. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-02-14 |
QS Pharma
Boothwyn, Pennsylvania, United States QS Pharma, LLC is a provider of a broad range of contract development/research and clinical/commercial manufacturing services for pharmaceutical and biopharmaceutical companies worldwide. |
Buy | - |
